Learn how to handle FDA warning letters for manufacturing violations. We break down CGMP compliance, common causes like data integrity failures, and step-by-step strategies for effective remediation.
Read More
Learn when and how to report rare adverse events from generic medications. Understand FDA MedWatch protocols, seriousness criteria, and why your report matters for drug safety.
Read More
Explore the year-by-year breakdown of annual savings from FDA generic drug approvals. Discover how new entries cut costs by 70%, totaling billions in economic relief.
Read More
Explore the safety and efficacy of biosimilar medications. We break down the science, real-world data, and cost benefits to help you understand if switching to a biosimilar is right for you.
Read More
Explore how global regulators like the FDA and EMA handle NTI generics. Learn about stricter bioequivalence standards, regional differences, and the challenges facing prescribers and manufacturers in 2026.
Read More
Explore the landscape of gastrointestinal combination products, including generic availability, patent expirations, and cost-saving alternatives. Learn how to navigate insurance authorizations and choose between branded combos and separate generics for better GI care.
Read More
Learn how PAMORAs like methylnaltrexone and naloxegol treat opioid-induced constipation by blocking gut receptors without affecting pain relief.
Read More
Discover the fascinating history of generic drugs in the US, from early standardization and the Hatch-Waxman Act to the modern era of biosimilars.
Read More
Explore the latest advances in bioequivalence testing, from AI tools like BEAM to virtual modeling and ICH M10 standards, reducing drug development timelines.
Read More
